BioDrone Therapeutics Inc.

BioDrone Therapeutics Inc. was incorporated in Seattle, WA in 2019 to facilitate the global business development for BioDrone™ platform technology developed by MDimune Inc. To expedite the commercialization of BioDrone™ technology with enormous therapeutic potentials, the company is currently focused on two key activities. First, BioDrone Therapeutics is actively seeking advanced technologies in diverse therapeutics areas that can be integrated into BioDrone™ platform. Next, the company is exploring partnership opportunities with global pharmaceutical companies to extend the therapeutic applications of BioDrone™ platform technology.